Uveitis in juvenile idiopathic arthritis.

BACKGROUND Juvenile idiopathic arthritis (JIA) is the most common systemic disease causing uveitis in childhood, with a prevalence of 10 per 100 000 persons. JIA often takes a severe inflammatory course, and its complications often endanger vision. METHODS This review is based on pertinent articles retrieved by a selective literature search up to 18 August 2014 and on the current interdisciplinary S2k guideline on the diagnostic evaluation and anti-inflammatory treatment of juvenile idiopathic uveitis. RESULTS Uveitis arises in roughly 1 in 10 patients with JIA. Regular eye check-ups should be performed starting as soon as JIA is diagnosed. 75-80% of patients are girls; antinuclear antibodies are found in 70-90%. The risk to vision is higher if JIA begins in the preschool years. As for treatment, only a single, small-scale randomized controlled trial (RCT) and a small number of prospective trials have been published to date. Topical corticosteroids should be given as the initial treatment. Systemic immunosuppression is needed if irritation persists despite topical corticosteroids, if new complications arise, or if the topical steroids have to be given in excessively high doses or have unacceptable side effects. If the therapeutic effect remains inadequate, conventional and biological immune modulators can be given as add-on (escalation) therapy. Treatment lowers the risk of uveitis and its complications and thereby improves the prognosis for good visual function. CONCLUSION Severely affected patients should be treated in competence centers to optimize their long-term outcome. Multidisciplinary, individualized treatment is needed because of the chronic course of active inflammation and the ensuing high risk of complications that can endanger vision. Future improvements in therapy will be aided by prospective, population-based registries and by basic research on biomarkers for the prediction of disease onset, prognosis, tissue damage, and therapeutic response.

[1]  Rutger M van den Bor,et al.  Development of Macular Edema and Impact on Visual Acuity in Uveitis Associated with Juvenile Idiopathic Arthritis* , 2015, Ocular immunology and inflammation.

[2]  N. Wulffraat,et al.  Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown. , 2014, Survey of ophthalmology.

[3]  A. Heiligenhaus,et al.  [Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis (as of 02. 07. 2014)]. , 2014, Klinische Monatsblatter fur Augenheilkunde.

[4]  S. Sauer,et al.  Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands zur intravitrealen Therapie des Makulaödems bei Uveitis , 2014, Klin Monatsbl Augenheilkd.

[5]  S. Yeh,et al.  A123: HLA Associations in a Matched Cohort of Juvenile Idiopathic Arthritis Children With and Without Uveitis , 2014 .

[6]  N. Barrowman,et al.  A13: The Research in Arthritis in Canadian Children Emphasizing Outcomes (ReACCh Out) Cohort: Prospective Determination of the Incidence of New Onset Uveitis in Juvenile Idiopathic Arthritis , 2014 .

[7]  A. Heiligenhaus,et al.  PReS-FINAL-2068: S100 A8/A9 serum levels reflect disease activity in juvenile idiopathic arthritis-associated uveitis , 2013, Pediatric Rheumatology.

[8]  M. Korpela,et al.  Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies. , 2013, Rheumatology.

[9]  A. Martini,et al.  Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis. , 2013, The Journal of pediatrics.

[10]  A. Heiligenhaus,et al.  Review for Disease of the Year: Epidemiology of Juvenile Idiopathic Arthritis and its Associated Uveitis: The Probable Risk Factors , 2013, Ocular immunology and inflammation.

[11]  D. Weakley,et al.  Dexamethasone intravitreal implant (Ozurdex) for the treatment of pediatric uveitis. , 2013, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[12]  R. Cimaz,et al.  Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry , 2013, The Journal of Rheumatology.

[13]  A. Heiligenhaus,et al.  Favourable outcome after cataract surgery with IOL implantation in uveitis associated with juvenile idiopathic arthritis , 2012, Acta ophthalmologica.

[14]  A. Heiligenhaus,et al.  Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis–associated uveitis: A consensus effort from the multinational interdisciplinary working group for uveitis in childhood , 2012, Arthritis care & research.

[15]  J. Gerss,et al.  Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study , 2012, Annals of the rheumatic diseases.

[16]  A. Heiligenhaus,et al.  Is Tocilizumab an Effective Option for Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis? , 2012, The Journal of Rheumatology.

[17]  A. Heiligenhaus,et al.  Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis , 2012, Rheumatology International.

[18]  J. Kempen,et al.  Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated With Juvenile Idiopathic Arthritis: The SITE Study , 2012 .

[19]  Kenneth W Griffin,et al.  Development of a vision‐related quality of life instrument for children ages 8–18 years for use in juvenile idiopathic arthritis–associated uveitis , 2011, Arthritis care & research.

[20]  A. Heiligenhaus,et al.  Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). , 2011, Rheumatology.

[21]  R. Cimaz,et al.  Prevention of flare recurrences in childhood‐refractory chronic uveitis: An open‐label comparative study of adalimumab versus infliximab , 2011, Arthritis care & research.

[22]  A. Rothova,et al.  Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. , 2011, American journal of ophthalmology.

[23]  P. Barceló,et al.  Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain) , 2010, Scandinavian journal of rheumatology.

[24]  A. Rothova,et al.  Long-term ocular complications in aphakic versus pseudophakic eyes of children with juvenile idiopathic arthritis-associated uveitis , 2010, British Journal of Ophthalmology.

[25]  R. Cimaz,et al.  Abatacept for severe anti–tumor necrosis factor α refractory juvenile idiopathic arthritis–related uveitis , 2010, Arthritis care & research.

[26]  J. Gerss,et al.  Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. , 2010, JAMA.

[27]  K. Minden,et al.  The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database. , 2009, Clinical and experimental rheumatology.

[28]  A. Heiligenhaus,et al.  Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis , 2009, Eye.

[29]  A. Heiligenhaus,et al.  Prevalence of Uveitic Secondary Glaucoma and Success of Nonsurgical Treatment in Adults and Children in a Tertiary Referral Center , 2009, Ocular immunology and inflammation.

[30]  K. Minden,et al.  Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. , 2008, The New England journal of medicine.

[31]  R. Saurenmann,et al.  Risk factors and longterm outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland. , 2008, The Journal of rheumatology.

[32]  A. Rothova,et al.  Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences. , 2008, American journal of ophthalmology.

[33]  A. Heiligenhaus,et al.  Methotrexate for Uveitis Associated with Juvenile Idiopathic Arthritis: Value and Requirement for Additional Anti-Inflammatory Medication , 2007, European journal of ophthalmology.

[34]  L. Kodjikian,et al.  Maculopathy in uveitis of juvenile idiopathic arthritis: an optical coherence tomography study , 2007, British Journal of Ophthalmology.

[35]  R. Saurenmann,et al.  Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. , 2007, Arthritis and rheumatism.

[36]  N. Bornfeld1,et al.  Maligne und nichtmaligne Uveitis-Maskierungssyndrome im Kindesalter , 2007 .

[37]  A. Heiligenhaus,et al.  Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. , 2007, Rheumatology.

[38]  N. Bornfeld,et al.  [Malignant and non-malignant uveitis-masquerade syndromes in childhood]. , 2007, Klinische Monatsblatter fur Augenheilkunde.

[39]  A. Heiligenhaus3,et al.  Diagnostik bei Uveitis im Kindesalter: Welche Tests bei welcher Uveitis? , 2007 .

[40]  A. Heiligenhaus,et al.  Diagnostik bei Uveitis im Kindesalter: Welche Tests bei welcher Uveitis? , 2007, Klinische Monatsblatter fur Augenheilkunde.

[41]  D. Jabs,et al.  Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. , 2007, American journal of ophthalmology.

[42]  D. Jabs,et al.  Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. , 2007, American journal of ophthalmology.

[43]  H. Penttilä,et al.  Intraocular Lens Implantation in Patients with Juvenile Idiopathic Arthritis-Associated Uveitis , 2006, Ophthalmic Research.

[44]  M. Zierhut,et al.  Adalimumab in the therapy of uveitis in childhood , 2006, British Journal of Ophthalmology.

[45]  E. Zeggini,et al.  Association of HLA-DRB1*13 with susceptibility to uveitis in juvenile idiopathic arthritis in two independent data sets. , 2006, Rheumatology.

[46]  A. Rothova,et al.  Ocular hypertension and secondary glaucoma in children with uveitis. , 2006, Ophthalmology.

[47]  S. Cha,et al.  Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[48]  Douglas A Jabs,et al.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. , 2005, American journal of ophthalmology.

[49]  M. Leirisalo-Repo,et al.  Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients , 2005, Annals of the rheumatic diseases.

[50]  Jonghyeon Kim,et al.  A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.

[51]  I. Foeldvari,et al.  Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. , 2005, The Journal of rheumatology.

[52]  A Ravelli,et al.  Toward an understanding of the long-term outcome of juvenile idiopathic arthritis. , 2004, Clinical and experimental rheumatology.

[53]  M. Suarez‐Almazor,et al.  International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .

[54]  N. Wulffraat,et al.  Visual loss in uveitis of childhood , 2003, The British journal of ophthalmology.

[55]  C. Edelsten,et al.  Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. , 2003, American journal of ophthalmology.

[56]  C. Edelsten,et al.  Visual loss associated with pediatric uveitis in english primary and referral centers. , 2003, American journal of ophthalmology.

[57]  V. Gerloni,et al.  Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis. , 2002, The Journal of rheumatology.

[58]  J. Kanski,et al.  An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood , 2002, The British journal of ophthalmology.

[59]  H. Kautiainen,et al.  Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. , 2001, Ophthalmology.

[60]  W. Christen,et al.  Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis. , 2000, Acta ophthalmologica Scandinavica.

[61]  J. Tuominen,et al.  Uveitis in children: population-based study in Finland. , 2000, Acta ophthalmologica.

[62]  U. Pleyer,et al.  Pseudophakia in children with juvenile arthritis , 1998, Der Ophthalmologe.

[63]  C. Rosé,et al.  Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. , 1997, The Journal of rheumatology.

[64]  R. Dana,et al.  Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. , 1997, Ophthalmology.

[65]  H. Valkenburg,et al.  The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. , 1991, Investigative ophthalmology & visual science.

[66]  P. Lichter,et al.  Prognostic factors in the uveitis of juvenile rheumatoid arthritis. , 1987, Ophthalmology.

[67]  J. J. Kanski Anterior uveitis in juvenile rheumatoid arthritis. , 1977, Archives of ophthalmology.

[68]  J. Kempen,et al.  Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. , 2013, Ophthalmology.

[69]  B. Andersson Gäre,et al.  Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. , 2003, The Journal of rheumatology.

[70]  O. Kaipiainen-Seppänen,et al.  A population-based study on uveitis in juvenile rheumatoid arthritis. , 1999, Clinical and experimental rheumatology.